STERIS Announces Financial Results for Fiscal 2024 Second Quarter
Second quarter revenue growth of 12% as reported and 8% constant currency organicAs reported diluted earnings per share increased to $1.16; adjusted earnings increased to $2.03Fiscal 2024 outlook...
United States Dan Carestio Company Contact Corporate Communications Life Sciences Chief Executive Officer
Source: marketscreener.com